These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5639737)

  • 1. Antifibrinolytic therapy for intracranial aneurysms.
    Mullan S; Dawley J
    J Neurosurg; 1968 Jan; 28(1):21-3. PubMed ID: 5639737
    [No Abstract]   [Full Text] [Related]  

  • 2. Streptokinase clot lysis time in patients with ruptured intracranial aneurysms.
    Geronemus R; Herz DA; Shulman K
    J Neurosurg; 1974 Apr; 40(4):499-503. PubMed ID: 4814382
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of antifibrinolytic substances in ruptured intracranial aneurysms.
    Norlén G; Thulin CA
    Neurochirurgia (Stuttg); 1969 May; 12(3):100-2. PubMed ID: 5790480
    [No Abstract]   [Full Text] [Related]  

  • 4. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
    Shucart WA; Hussain SK; Cooper PR
    J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifibrinolytics in the treatment of subarachnoid hemorrhages due to ruptured aneurysms.
    Schisano G
    J Neurosurg Sci; 1975; 19(1-2):79-80. PubMed ID: 1082929
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring antifibrinolytic therapy in subarachnoid hemorrhage.
    Smith RR; Upchurch JJ
    J Neurosurg; 1973 Mar; 38(3):339-44. PubMed ID: 4268202
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.
    Nibbelink DW; Torner JC; Henderson WG
    Stroke; 1975; 6(6):622-9. PubMed ID: 1198627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of antifibrinolytic, edema-preventing and hypotensive agents in the prevention of recurrent bleeding from intracranial aneurysms].
    Bromowicz J; Bryniarska D; Koniar-Danilewicz H; Danilewicz B
    Neurol Neurochir Pol; 1979; 13(6):647-51. PubMed ID: 514441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of antifibrinolytic therapy for treatment of patients with aneurysmal subarachnoid hemorrhage.
    Adams HP
    Stroke; 1982; 13(2):256-9. PubMed ID: 7039006
    [No Abstract]   [Full Text] [Related]  

  • 10. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrinolytic activity during administration of epsilon-aminocaproic acid.
    Nibbelink DW
    Stroke; 1971; 2(6):555-8. PubMed ID: 5164583
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy.
    Spallone A
    Acta Neurochir (Wien); 1982; 63(1-4):245-50. PubMed ID: 6179402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
    Adams HP; Nibbelink DW; Torner JC; Sahs AL
    Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania.
    Corkill G
    Med J Aust; 1974 Mar; 1(13):468-70. PubMed ID: 4830928
    [No Abstract]   [Full Text] [Related]  

  • 15. Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid.
    Sonntag VK; Stein BM
    J Neurosurg; 1974 Apr; 40(4):480-5. PubMed ID: 4814379
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study.
    Kassell NF; Torner JC; Adams HP
    J Neurosurg; 1984 Aug; 61(2):225-30. PubMed ID: 6737046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
    Burchiel KJ; Schmer G
    J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of aminocaproic acid and nicardipine in treatment of aneurysmal subarachnoid hemorrhage.
    Beck DW; Adams HP; Flamm ES; Godersky JC; Loftus CM
    Stroke; 1988 Jan; 19(1):63-7. PubMed ID: 3336904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.?211.
    Shaw MD; Miller JD
    Lancet; 1974 Oct; 2(7884):847-8. PubMed ID: 4138300
    [No Abstract]   [Full Text] [Related]  

  • 20. Antifibrinolytic therapy in the treatment of subarachnoid haemorrhage caused by arterial aneurysms.
    Profeta G; Castellano F; Guarnieri L; Cigliano A; Amborsio A
    J Neurosurg Sci; 1975; 19(1-2):77-8. PubMed ID: 1221103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.